{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:56:11Z","timestamp":1794441371365,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>\n                    Primary cutaneous CD4\n                    <jats:sup>+<\/jats:sup>\n                    small\/medium T-cell lymphoproliferative disorder (PCSMLPD) is a recently recognized entity in the 2017 World Health Organization (WHO) classification. It belongs to the T-follicular helper (TFH) lymphoproliferations. The clinical, pathologic, and molecular features of this localized disease are underresearched. We conducted a retrospective multicentric study of 60 patients with a PCSMLPD that presented as a single cutaneous lesion. Clinical, pathologic, and targeted molecular analyses were performed. PCSMLPD presented mostly as a nodule (45%), located on the head and neck area (50%) in adults (mean age: 59\u2009y [43.3 to 75.2]). All patients had an indolent disease course, either at initial staging or during follow-up (mean: 16.6\u2009mo [1.3 to 31.9]). Spontaneous regression was reported in 31.9% of cases. The infiltrates were most often nodular and\/or diffuse, expanding in the whole dermis (78%, Pattern 1), rather than subepidermal band-like in the superficial dermis (22%, Pattern 2). Epidermotropism, folliculotropism, and capillary hyperplasia were common. The expression of TFH lineage markers was more extensive in lesions with Pattern 2, but a substantial B-cell infiltrate was seen in both types of lesions. A clonal rearrangement of the TCR genes was identified in 68% of cases. One sample of the 13 tested revealed a mutation in the\n                    <jats:italic toggle=\"yes\">DNMT3A<\/jats:italic>\n                    gene among the 9 genes studied (\n                    <jats:italic toggle=\"yes\">TET2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DNMT3A<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">IDH2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">RHOA<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">SETD2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">STAT3<\/jats:italic>\n                    , STAT5B, and\n                    <jats:italic toggle=\"yes\">CD28<\/jats:italic>\n                    ). PCSMLPD follows a benign clinical course and can spontaneously regress after biopsy. Although PCSMLPD expresses TFH lineage markers, mutations usually found in angioimmunoblastic T-cell lymphomas are uncommon.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001470","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T02:26:56Z","timestamp":1586399216000},"page":"862-872","source":"Crossref","is-referenced-by-count":74,"title":["Primary Cutaneous CD4+ Small\/Medium T-Cell Lymphoproliferative Disorders"],"prefix":"10.1097","volume":"44","author":[{"given":"Fanny","family":"Beltzung","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pelletier","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bordeaux Universitary Hospital"},{"name":"INSERM U1053 Team 3 Oncogenesis of Cutaneous Lymphomas, Bordeaux Univsersity, Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, APHP Henri Mondor Hospital, Cr\u00e9teil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Franck","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[{"name":"Biostatistics Unit (DRCI), Clermont-Ferrand Universitary Hospital, Clermont-Ferrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godfraind","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Delfau","sequence":"additional","affiliation":[{"name":"Biological Immunology, APHP Henri Mondor Hospital, Paris Est Creteil University (UPEC) and INSERM U955 Team Ortonne (NFL)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"D\u2019Incan","sequence":"additional","affiliation":[{"name":"Dermatology, Clermont-Ferrand Universitary Hospital, Estaing Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[{"name":"INSERM U1053 Team 3 Oncogenesis of Cutaneous Lymphomas, Bordeaux Univsersity, Bordeaux"},{"name":"Department of Pathology, Bordeaux Univsersitary Hospital, Haut-L\u00e9v\u00eaque Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archdermatol.2011.3269","article-title":"Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases","volume":"148","author":"Battistella","year":"2012","journal-title":"Arch Dermatol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2559.2010.03498.x","article-title":"Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases","volume":"56","author":"Le Tourneau","year":"2010","journal-title":"Histopathology"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"suppl 4","key":"R8-20230922","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdr181","article-title":"Primary cutaneous lymphomas","volume":"22","author":"Willemze","year":"2011","journal-title":"Ann Oncol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpainsymman.2014.06.006","article-title":"Comparison of ECOG\/WHO performance status and ASA score as a measure of functional status","volume":"49","author":"Young","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/PAS.0000000000000091","article-title":"CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact","volume":"37","author":"Julli\u00e9","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<185::AID-PATH997>3.0.CO;2-9","article-title":"Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides","volume":"184","author":"Delfau-Larue","year":"1998","journal-title":"J Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","article-title":"Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma","volume":"96","author":"Delfau-Larue","year":"2000","journal-title":"Blood"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.0022-202x.2001.01476.x","article-title":"Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas","volume":"117","author":"Beylot-Barry","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0000000000000261","article-title":"The curious origins of angioimmunoblastic T-cell lymphoma","volume":"23","author":"Cort\u00e9s","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/0008-5472.CAN-17-0337","article-title":"Variant Review with the Integrative Genomics Viewer (IGV)","volume":"77","author":"Robinson","year":"2017","journal-title":"Cancer Res"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4 + primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.13340","article-title":"Long-term follow-up and management of small and medium-sized CD4(+) T cell lymphoma and CD8(+) lymphoid proliferations of acral sites: a multicenter experience","volume":"55","author":"Virmani","year":"2016","journal-title":"Int J Dermatol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/cup.12806","article-title":"Clinicopathological and molecular study of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma","volume":"43","author":"Alberti-Violetti","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.3390\/ijms14046720","article-title":"Cytokines and the skin barrier","volume":"14","author":"H\u00e4nel","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12307-012-0127-6","article-title":"Effector CD4 and CD8 T cells and their role in the tumor microenvironment","volume":"6","author":"Hadrup","year":"2012","journal-title":"Cancer Microenviron"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"pii: eaan0368","DOI":"10.1126\/sciimmunol.aan0368","article-title":"Tfr cells lack IL-2R\u03b1 but express decoy IL-1R2 and IL-1Ra and suppress the IL-1-dependent activation of Tfh cells","volume":"2","author":"Ritvo","year":"2017","journal-title":"Sci Immunol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.0736-8046.2004.21507.x","article-title":"Unilesional (segmental) mycosis fungoides presenting in childhood","volume":"21","author":"Alsaleh","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1346-8138.2003.tb00409.x","article-title":"Unilesional mycosis fungoides mimicking Bowen\u2019s disease","volume":"30","author":"Yoo","year":"2003","journal-title":"J Dermatol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DAD.0b013e31821c35cb","article-title":"Expression patterns of the immunosuppressive proteins PD-1\/CD279 and PD-L1\/CD274 at different stages of cutaneous T-cell lymphoma\/mycosis fungoides","volume":"34","author":"Kantekure","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/DAD.0000000000000258","article-title":"Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas","volume":"37","author":"Bosisio","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1684\/ejd.2016.2847","article-title":"The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation","volume":"26","author":"Iliadis","year":"2016","journal-title":"Eur J Dermatol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides","volume":"148","author":"Cetin\u00f6zman","year":"2012","journal-title":"Arch Dermatol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1155\/2010\/404069","article-title":"Diagnostic and prognostic utility of PD-1 in B cell lymphomas","volume":"29","author":"Muenst","year":"2010","journal-title":"Dis Markers"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2559.2007.02632.x","article-title":"Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics","volume":"50","author":"Attygalle","year":"2007","journal-title":"Histopathology"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"J Mol Diagn"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/17474086.2013.845000","article-title":"Cutaneous pseudolymphomas: inflammatory reactive proliferations","volume":"6","author":"Hussein","year":"2013","journal-title":"Expert Rev Hematol"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.path.2017.01.002","article-title":"Cutaneous pseudolymphoma","volume":"10","author":"Mitteldorf","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4103\/0019-5154.185698","article-title":"Approach to cutaneous lymphoid infiltrates: when to consider lymphoma?","volume":"61","author":"Charli-Joseph","year":"2016","journal-title":"Indian J Dermatol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/cup.12204","article-title":"Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype","volume":"40","author":"Buder","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/PAS.0000000000000956","article-title":"Expression of TFH markers and detection of RHOA p.G17V and IDH2 p.R172K\/S mutations in cutaneous localizations of angioimmunoblastic T-cell lymphomas","volume":"41","author":"Leclaire Alirkilicarslan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2353\/ajpath.2010.091286","article-title":"Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma","volume":"177","author":"Tripodo","year":"2010","journal-title":"Am J Pathol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2017.167973","article-title":"Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas","volume":"103","author":"Lemonnier","year":"2018","journal-title":"Haematologica"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T14:17:39Z","timestamp":1722694659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001470"}},"subtitle":["A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group"],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001470","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737713106.793574594","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}